TACROLIMUS - ANVISA Registration 80146502080

Access comprehensive regulatory information for TACROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502080 and manufactured by ABBOTT LABORATORIES DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Feb 26, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146502080
2 Related Devices
Registration Details
ANVISA Registration Number: 80146502080
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família ARCHITECT Tacrolimus
Risk Class III

Registration Details

80146502080

25351407263201798

56998701000116

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Feb 26, 2018

26/02/2028

09/18/2025 19:00:01

Família ARCHITECT Tacrolimus
Risk Class III

Registration Details

80146502080

25351407263201798

56998701000116

Company Information

Dates and Status

Feb 26, 2018

26/02/2028

09/18/2025 19:00:01